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Background: The optimal timing of pulmonary homograft valve replacement (PVR) is uncertain. Cardiopulmonary
exercise testing (CPET) and cardiac magnetic resonance (CMR) are often used to guide the clinical decision for PVR
in operated tetralogy of Fallot (TOF) patients with significant pulmonary regurgitation (PR). We aim to study the
relationship between exercise capacity and CMR in these patients.
Methods: The study is a single-centre retrospective analysis of 36 operated TOF patients [median 21.4 (interquartile
range 16.4, 26.4) years post-repair; 30 NYHA I, 6 NYHA II; median age 25.2 (interquartile range 19.5-31.7) years, 29
males] with significant PR on CMR who underwent CPET within 15 [median 2.0 (interquartile range 0.8-7.2)] months
from CMR. CPET parameters were compared with 30 age- and sex-matched healthy controls [median age 27.8
(interquartile range 21.0-32.8) years; 24 males].
Results: Peak systolic blood pressure (177 versus 192 mmHg, p = 0.007), Mets (7.3 versus 9.9, p < 0.001), peak oxygen
consumption (VO2max) (29.2 versus 34.5 ml/kg/min, p < 0.001) and peak oxygen pulse (11.0 versus 13.7 ml/beat,
p = 0.003) were significantly lower in TOF group versus control. Univariate analyses showed negative correlation
between PR fraction and anaerobic threshold. There was a positive correlation between indexed left (LV) and right (RV)
ventricular end-diastolic volumes, as well as indexed LV and effective RV stroke volumes, on CMR and VO2max and Mets
achieved on CPET. These remained significant after adjustment for age and sex.
Conclusions: TOF subjects have near normal exercise capacity but significantly lower Mets, VO2max and peak oygen
pulse achieved compared to controls. Increased PR fraction in TOF subjects was associated with lower anaerobic
threshold. Higher indexed effective RV stroke volume, a measure of LV preload, was associated with higher VO2max
and Mets achieved, and may potentially be used as a predictor of exercise capacity.
Keywords: Exercise capacity, Cardiac magnetic resonance imaging, Tetralogy of Fallot* Correspondence: tan.ru.san@nhcs.com.sg
1Department of Cardiology, National Heart Centre Singapore, 5 Hospital
Drive, Singapore 169609, Singapore
2Duke-NUS Graduate Medical School, Singapore, 8 College Rd, Singapore
169857, Singapore
© 2014 Yap et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Yap et al. BMC Cardiovascular Disorders 2014, 14:122 Page 2 of 9
http://www.biomedcentral.com/1471-2261/14/122Background
Long-term outcomes of patients with tetralogy of Fallot
(TOF) have improved with advances in surgical tech-
niques [1]. However, pulmonary regurgitation (PR)
resulting from repair to the right ventricular outflow
tract is a common consequence of the primary surgery.
This is usually well tolerated initially, but leads to increased
right ventricular (RV) dilatation, dysfunction and worsening
exercise intolerance over time, and may result in
arrhythmia and sudden cardiac death [2-4].
The optimal timing of pulmonary homograft valve
replacement (PVR) in operated TOF patients with sig-
nificant PR is unclear. The decision for PVR is usually a
fine balance between avoiding permanent remodeling of
the right ventricle [5,6] and reducing the need for repeat
procedures throughout one’s lifetime in these often
young patients. Cardiopulmonary exercise testing (CPET)
and cardiac magnetic resonance (CMR) are two important
tools often used by clinicians to help guide this difficult
management decision [5,6].
Poor exercise capacity identifies patients at higher risk
of hospitalization and mortality [7-9] and guidelines have
listed decreasing exercise tolerance as a strong indication
for PVR [10-12]. The American College of Cardiology/
American Heart Association (ACC/AHA) 2008 guidelines
recommend PVR as a Class I indication in operated TOF
patients with severe PR and decreased exercise tolerance
[12]; exercise testing is a useful adjunct. A Class IIa indica-
tion for PVR is in patients with severe PR and moderate
to severe RV enlargement [12]. The exact definition of
moderate to severe RV dysfunction/enlargement is not
clear. The European Society of Cardiology (ESC) 2010
guidelines have similar recommendations but suggest
using a RVEDVi cut-off of 160 ml/m2, beyond which
normalization of RV becomes unlikely [10]. The Canadian
Cardiovascular Society (CCS) 2009 guidelines recommend
as a Class IIa indication that PVR should be consid-
ered in TOF patients with severe PR who have either a
deterioriating exercise performance or moderate to
severe RV enlargement (RVEDVi >170 ml/m2) [11]. A
RVEDVi cut-off of 150 ml/m2 is sometimes used
clinically [13]. A recent study found similar exercise
capacity and stroke volumes in patients below and
above the threshold, thus raising questions about the
utility of RVEDVi as the main basis for deciding on
timing for PVR [14].
The relationship between CMR parameters and actual
exercise capacity remains unclear. Understanding the
relationship between exercise capacity and CMR pa-
rameters is important and may better help rationalize
the clinical decision for PVR. We aim to study the
exercise capacity in TOF patients with significant PR
late (>10 years) after repair and its relationship with
CMR parameters.Methods
Study design and patient population
In our institution, operated adult TOF patients with
significant (at least moderate) PR on TTE will undergo
CMR and CPET as part of their clinical management.
The study is a retrospective review of all consecutive
patients with surgically corrected TOF and known
significant (moderate to severe) PR on TTE, who
underwent CMR and CPET at our institution from Apr
2005 to Mar 2013. All patients were older than 15 years
of age and had undergone corrective surgery for TOF
more than 10 years previously [median 21.4 years (IQR
16.4, 26.4)]. Patients with residual pulmonary stenosis
pressure gradient on Doppler echocardiography, asso-
ciated atrioventricular septum defect, double outlet
right ventricle of Fallot type, pulmonary atresia with
ventricular septum defect, TOF with absent pulmonary
valve, or patients who had undergone pulmonary valve
replacement (PVR) were excluded. Clinical data were
obtained from review of patients’ case-files and electronic
medical records.
CMR and CPET data were recorded. CPET data were
also obtained from age- and sex-matched healthy controls.
The study was approved by the SingHealth Centralised
Institutional Review Board (SingHealth, Singapore).
Cardiac MRI
Study subjects underwent CMR on a 1.5 T Avanto scanner
(Siemens). In each patient, fast imaging in steady-state
precession (trueFISP) cine MR images were acquired in
the left ventricular (LV) long axes (2-, 3- and 4-chamber
views), RV outflow tract (RVOT) (oblique sagittal and cor-
onal) planes as well as a parallel contiguous stack of 8 mm
ventricular short-axis cine slices. Retrospective ECG-
triggering was employed, achieving typical frame rates
of about 25 per cardiac cycle. Throughplane flow mea-
surements in planes across the aortic root and main
pulmonary trunk were performed using velocity-encoded
gradient-echo pulse sequences.
Calculation of left and right ventricular end-diastolic
(EDV) and end-systolic (ESV) volumes, LV mass and
ejection fractions (EF) was performed using CMRTools
(London, UK). All volumes and LV mass measurements
were then indexed to body surface area. The presence of
RVOT aneurysm, defined as akinesia or dyskinesia
(outward movement) during systole of part of the
RVOT assessed from the basal ventricular short-axis
cine images, was recorded. PR fraction (diastolic re-
verse flow expressed as a percentage of forward flow)
was assessed from anterograde and retrograde flow in
the main pulmonary artery (ARGUS software, Siemens,
Erlangen). Effective right ventricular stroke volume
(RVSV) was calculated as the difference between the
total RV forward flow and the pulmonary regurgitant
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by presence of end-diastolic forward pulmonary flow,
consistent with severely limited RV capacitance during
right atrial contraction.
Cardiopulmonary exercise testing
Cardiopulmonary exercise tests were performed on a
Hewlett-Packard Cosmos treadmill machine. A maximal
ramp protocol with fixed treadmill speed but constantly
increasing incline gradient to provide an increasing
workload was employed. Exercise speed was determined
at the performing physician's discretion. Patients were
encouraged to exercise until symptoms were intolerable,
i.e. when Rating of Perceived Exertion reached 18/20.
Heart rate was monitored continuously, and non-invasive
blood pressure was taken every 2 minutes with both man-
ual and automatic blood pressure. Oxygen saturation was
monitored by a finger probe pulse oximeter. Oxygen up-
take (VO2), minute ventilation (VE), and carbon dioxide
output (VCO2) were measured breath by breath. The an-
aerobic threshold (AT) was chosen as the VO2 at which
respiratory exchange ratio reached 1.0 and when there
was a sudden and sustained precipitous rise in VCO2.
Peak VO2 was defined as the value of averaged data during
the final 15 seconds of exercise. The VE/VCO2 slope was
determined as the linear regression slope of VE and VCO2.
Statistical analysis
Data was analysed using STATA version 11.1 (College
Station, Texas, USA). All values were presented as median
and interquartile range for continuous data and frequency
and percentage for categorical data. Comparisons between
groups were made with Mann–Whitney U test, or the
Fisher’s exact test as appropriate. The linear correlation, r,
between exercise testing and CMR parameters were
initially assessed using Pearson correlation coefficient
with 95% confidence interval (CI). Significant relationships
were subsequently assessed by multiple linear regression
technique adjusting for age and gender. Scatter plots with
linear fit were produced. For all analyses, a two-tailed
P value of <0.05 was considered significant.
Results
Baseline clinical characteristics
Of the 119 TOF patients on clinical follow-up at our in-
stitution at the beginning of the study, 36 had significant
PR on echocardiography. The latter underwent CPET
and CMR testing and were included in this study. Thirty
controls were also recruited. There was no significant
difference in age, sex and indexed body mass between
patients and controls. Six TOF patients had NYHA II
functional status; the rest of the study TOF population
were either asymptomatic or NYHA I (Table 1).CPET parameters
Compared to controls, TOF patients achieved significantly
lower maximum systolic blood pressure (177 versus
192 mmHg, p = 0.007), Mets (7.3 versus 9.9, p < 0.001),
peak oxygen consumption (29.2 versus 34.5 ml/kg/min,
p < 0.001) and peak oxygen pulse pressure (11.0 versus
13.7 ml/beat, p = 0.003). These differences were signifi-
cant even after adjusting for age and sex. There were no
significant difference in the rest of the CPET parameters
(Table 1). 7 TOF patients experienced arrhythmia during
CPET, all consisting of occasional isolated premature ven-
tricular complexes. No malignant arryhtmia was noted.
Medication, Surgical and CMR findings in TOF patients
The majority of the TOF patients were not on any cardiac
medications: one patient was on beta-blocker and ACE
inhibitor; one patient, ACE inhibitor and diuretics; and
one patient, beta-blocker alone. The median age at which
surgical repair was performed was 3.7 years (IQR 2.3-6.9)
and the median time from surgical repair was 21.4 years
(IQR 16.4-26.4). Ten patients (27.8%) had undergone
transannular patch repair (Table 2). All patients were in
sinus rhythm.
The median RVEDVi, RVESVi, RVEF, RVSVi, effective
RVSVi and PR fraction were 167.7 ml/m2 (IQR 142.5-
178.5), 87.2 ml/m2 (IQR 75.8-98.4), 45.6% (IQR 39.2-50.0),
73.5 ml/m2 (IQR 61.8-82.9), 41.1 ml/m2 (37.9-44.3) and
45.0% (IQR 35.5-52), respectively. The median LVEDVi,
LVESVi, LVEF and LVSVi were 73.1 ml/m2 (IQR 66.6-
82.5), 30.4 ml/m2 (IQR 26.9-35.3), 58.7% (IQR 52.9-62.3)
and 43.1 ml/m2 (IQR 39.0-48.1), respectively. All patients
had LVEF >40%, with five (13.9%) patients having LVEF
between 40-50%. Twenty-six (72.2%) had restrictive RV
physiology; and 20 (55.6%), RVOT aneurysms (Figure 1).
Relationship between CPET and CMR parameters in TOF
patients
The median time between CPETand CMR was 2.0 months
(IQR 0.8-7.2); there was no change in clinical status be-
tween CPET and CMR for all patients. Larger RVEDVi
(r = 0.36, 95% CI 0.03-0.62, p = 0.035), RVESVi (r = 0.35,
95% CI 0.01-0.61, p = 0.042) and LVEDVi (r = 0.39, 95%
CI 0.06-0.64, p = 0.021) were associated with signifi-
cantly higher Mets achieved during exercise testing.
Larger RVEDVi (r = 0.35, 95% CI 0.03-0.61, p = 0.037)
and LVEDVi (r = 0.35, 95% CI 0.03-0.61, p = 0.030) were
associated with higher peak oxygen consumption achieved
during exercise testing. Larger LVSVi (r = 0.37, 95% CI
0.04-0.62, p = 0.030) and effective RVSVi (r = 0.53, 95% CI
0.24-0.73, p = 0.001) were associated with significantly
higher Mets achieved. Larger LVSVi (r = 0.35, 95% CI
0.02-0.61, p = 0.037) and effective RVSVi (r = 0.53, 95% CI
0.24-0.73, p < 0.001) were associated with significantly
higher peak oxygen consumption. Greater PR fraction was
Table 1 Demographics and CPET parameters of study population (n = 66)
TOF (n = 36) Control (n = 30) P value Adjusted P value*
Demographics
Age 25.2 (19.5, 31.7) 27.8 (21.0, 32.8) 0.20
Male 29 (80.6) 24 (80.0) 1.00
BMI (kg/m2) 22.8 (21.0, 26.3) 23.2 (19.6, 25.6) 0.39
Asymptomatic/NYHA I 30 (83.3) 30 (100.0) 0.03
CPET parameters
Max HR (beats/min) 172.5 (159, 178) 176.5 (168, 181) 0.257 0.429
Heart rate reserve (beats/min) 26.5 (8, 39) 15.5 (7, 20) 0.117 0.183
Max SBP (mmHg) 177 (150, 184) 192 (168, 210) 0.007 0.010
Max DBP (mmHg) 86 (78, 93) 82 (76, 97) 0.575 0.964
Max breathing reserve (L/min) 38 (21, 72.1) 47.8 (34.5, 61.3) 0.540 0.602
Mets 8.3 (7.1, 9.4) 9.9 (8.6,11.7) <0.001 <0.001
% predicted Mets (%) 85.0 (74.8, 93.9) 102.7 (91.1, 114.5) <0.001 <0.001
Peak oxygen consumption (ml/kg/min) 29.2 (25.5, 33.0) 34.5 (30.0, 41.0) <0.001 <0.001
% predicted peak oxygen consumption (%) 83.0 (72.0, 93.5) 102.7 (91.1, 114.8) <0.001 <0.001
Anaerobic threshold (ml/min) 1395 (1170, 1574) 1501.5 (1255, 1700) 0.231 0.211
Oxygen pulse pressure (ml/beat) 11.0 (8.8, 13.2) 13.7 (11.9, 16.2) 0.003 0.002
VE/VCO2 slope 26.0 (23.6, 27.3) 25.6 (24.1, 27.2) 1.00 0.576
Arrhythmias** 7 (19.4) 4 (13.3) 0.742 0.492
Median and interquartile ranges are reported for continuous data and frequency and percentage for categorical data.
*Adjusted for age and gender.
**All were occasional ventricular or atrial ectopics.
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p = 0.020)(see Table 3). After adjusting for age and sex, all
these relationships remained significant (Table 4, Figure 2).
Of note, there was no significant correlation between
exercise data and either RVEF or RVSV. ComparingTable 2 Medication, Surgical and CMR Data of TOF
patients (n = 36)
TOF (n = 36)
Medication data
Beta-blockers 2 (5.6%)




Age of surgical repair 3.69 (2.26, 6.93)
Time from surgical repair 21.4 (16.4, 26.4)
Transannular patch* 10 (27.8)
Pulmonary outflow patch* 4 (11.1)
RV to pul artery conduit* 4 (11.1)
Previous palliative shunt 4 (11.1)
Median and interquartile ranges are reported for continuous data and
frequency and percentage for categorical data.
*Complete surgical data missing in 6 patients.TOF patients with and without restrictive RV physiology,
no significant difference in CPET parameters was ob-
served. This was the same among those with and without
RVOT aneurysms. There was also no significant associ-
ation between the rest of the CMR parameters and CPET
observations.
Discussion
Our operated TOF patients with significant PR had near
normal exercise capacity, albeit lower than that of normalFigure 1 Box plot showing distribution of CMR data.
Table 3 Relationship between exercise testing and RV and LV function/volume in TOF patients (n = 36)















RVEDVi 0.15 (−0.20, 0.46) 0.36 (0.03, 0.62)* 0.31 (−0.04, 0.59) 0.35 (0.03, 0.61)* 0.24 (−0.10, 0.52) −0.03 (−0.36, 0.31) −0.02 (−0.35, 0.31) −0.15 (−0.46, 0.20)
RVESVi 0.25 (−0.10, 0.54) 0.35 (0.01, 0.61)* 0.28 (−0.07, 0.57) 0.31 (−0.02, 0.58) 0.18 (−0.16, 0.48) 0.12 (−0.23, 0.44) −0.08 (−0.40, 0.26) −0.16 (−0.47, 0.19)
RVEF −0.31 (−0.59, 0.03) −0.16 (−0.47, 0.18) −0.10 (−0.43, 0.25) −0.12 (−0.43, 0.22) −0.01 (−0.34, 0.32) −0.25 (−0.54, 0.10) 0.15 (−0.19, 0.46) 0.09 (−0.26, 0.42)
RVSVi −0.13 (−0.45, 0.22) 0.16 (−0.18, 0.47) 0.18 (−0.17, 0.50) 0.18 (−0.15, 0.48) 0.18 (−0.15, 0.48) −0.26 (−0.55, 0.09) 0.10 (−0.23, 0.42) −0.05 (−0.38, 0.29)
Effective RVSVi −0.18 (−0.49, 0.16) 0.53 (0.24, 0.73)** 0.45 (0.13, 0.69)** 0.53 (0.24, 0.73)** 0.53 (0.24, 0.73)** 0.20 (−0.15, 0.50) 0.28 (−0.06, 0.55) −0.12 (−0.44, 0.23)
PR Fraction 0.07 (−0.27, 0.40) −0.33 (−0.60, 0.004) −0.24 (−0.54, 0.12) −0.30 (−0.57, 0.03) −0.33 (−0.59, 0.002) −0.40 (−0.65, −0.07)* −0.18 (−0.48, 0.16) 0.02 (−0.32, 0.36)
LVEDVi 0.19 (−0.16, 0.50) 0.39 (0.06, 0.64)* 0.05 (−0.30, 0.38) 0.35 (0.03, 0.61)* 0.11 (−0.23, 0.42) 0.23 (−0.12, 0.53) −0.02 (−0.35, 0.31) −0.11 (−0.43, 0.24)
LVESVi 0.18 (−0.17, 0.49) 0.27 (−0.07, 0.55) −0.06 (−0.40, 0.29) 0.23(−0.11, 0.52) −0.05 (−0.37, 0.28) 0.20 (−0.15, 0.50) −0.03 (−0.36, 0.30) −0.02 (−0.36, 0.32)
LVEF −0.07 (−0.40, 0.28) −0.06 (−0.39, 0.28) 0.13 (−0.22, 0.45) −0.04 (−0.36, 0.29) 0.19 (−0.15, 0.49) −0.13 (−0.45, 0.22) 0.04 (−0.29, 0.36) −0.09 (−0.42, 0.26)
LVSVi 0.11(−0.23, 0.43) 0.37 (0.04, 0.62)* 0.18 (−0.17, 0.50) 0.35 (0.02, 0.61)* 0.28(−0.05, 0.56) 0.15 (−0.20, 0.47) 0.01 (−0.32, 0.34) −0.20 (−0.50, 0.15)





















Table 4 Correlates of CPET parameters on CMR parameters with multiple linear regression analysis adjusting for age
and gender
CPET MRI Adjusted r 95% CI P R2,%
Mets RVEDVi 0.41 (0.07, 0.67) 0.019 40.3
RVESVi 0.35 (0.0004, 0.62) 0.047 37.2
Effective RVSVi 0.57 (0.28, 0.77) 0.001 51.9
LVEDVi 0.36 (0.02, 0.63) 0.036 38.1
LVSVi 0.39 (0.04, 0.65) 0.026 39.2
% predicted Mets Effective RVSVi 0.42 (0.08, 0.68) 0.017 23.3
Peak oxygen consumption RVEDVi 0.40 (0.06, 0.65) 0.019 43.7
Effective RVSVi 0.58 (0.29, 0.77) <0.001 55.4
LVEDVi 0.35 (0.003, 0.62) 0.045 41.1
LVSVi 0.37 (0.04, 0.64) 0.029 42.4
% predicted peak oxygen consumption Effective RVSVi 0.52 (0.21, 0.73) 0.002 28.2
Anaerobic threshold PR Fraction −0.40 −0.66, −0.05 0.023 41.2
Figure 2 Scatter plots with linear fit showing relationship between CPET and CMR parameters (r and P value were adjusted for age
and gender).
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because of differences in cohort characteristics, the exer-
cise capacity in our operated TOF patients with significant
PR is fairly similar to a published series [8] and better
compared to others [7,17]. These latter studies included
patients with all degrees of PR, unlike our study in which
only patients with significant PR on echocardiography
were studied with CMR and CPET. In clinical practice,
only patients with significant PR routinely undergo sur-
veillance cardiac MR. Our study thus provides clinically-
relevant data in the subset of patients with significant PR.
We demonstrated a negative correlation between PR
fraction and AT, implying a possible deleterious effect
on exercise capacity of worsening PR per se. The AT is
decreased in patients with heart disease and is an im-
portant functional limit: physiological responses to
exercise are different above and below the AT [18].
While low AT in heart failure patients is associated
with increased mortality [19], the prognostic value of
AT in TOF patients has not been previously studied.
In our study, we found that higher effective RV stroke
volume correlated significantly with higher Mets and
peak oxygen consumption. In contrast, we found no
significant correlation between exercise capacity and ei-
ther RVEF or RV stroke volume, which is in keeping with
reported studies [14,20]. In our TOF cohort, which has
similar distribution of RV and LV volume and ejection
fraction parameters to that of other studies [14,21], the
majority had normal LV function. Conceivably, the main
determinant of cardiac output (and thereby exercise cap-
acity) would thus be LV preload. In patients with signifi-
cant PR, LV preload may best be assessed by effective
RVSVi as LV preload is determined by the actual net RV
forward flow, taking into account the degree of PR.
That LV preload may play an important role in deter-
mining exercise capacity is further supported by the obser-
vation that both RV and LV end-diastolic volumes - both
indirect estimates of LV preload - showed positive correl-
ation with Mets achieved and peak VO2, albeit not as
strong a correlation as effective RVSVi. This appears to
be counter-intuitive to the commonly held notion that
increasingly dilated ventricular volumes equates with
worsening exercise capacity. However, our results are by
no means unique. There was a trend towards higher
peak VO2 with increasing biventricular diastolic volumes
in another study [20]. Similar to our findings, a recent
study of 55 operated TOF patients found significant posi-
tive correlation between LVEDVi and peak work achieved
[14]. They also found that exercise capacity between
patients with and without RV dilation was similar. Sup-
porting this notion, another study comparing treated
pulmonary stenosis and TOF patients found similar
exercise capacities and biventricular function in both
groups, despite worse PR and larger RV volumes in TOFpatients [22]. Our observations, as well as as those of
other investigators, call into question the presumption
that RV dilation necessarily means impaired exercise
tolerance.
Questions have been raised regarding the use of RV
size as a primary parameter in deciding the timing of
PVR. Studies have found that exercise capacity and
stroke volume are preserved late after tetrology repair,
despite severe right ventricular dilation [14]. There are
several postulations for this. Firstly, this may represent
adaptive LV and RV remodeling in well-compensated
TOF subjects. Of note, our TOF subjects had near-
normal exercise capacities, indicating a good degree of
compensation, despite their significant PR. Furthermore,
our study has shown that exercise capacity correlates
with stroke volumes, supporting the notion that proper
adaptation to volume overload of RV could be helpful
for preservation of functional capacity. This phenomenon
is well recognized in left ventricular physiology among
elite athletes [23,24]. Secondly, PR results in a dilated but
not hypertrophied RV. RV dilation exerts lesser impact on
oxygen saturation and LV function, so long as RV stroke
volume is maintained. Hence, exercise capacity is rela-
tively well preserved [14]. This notion is supported by our
observation that effective RV stroke volume is a significant
determinant of exercise capacity. The potential of effective
RVSVi as an indirect indicator of LV preload, and there-
fore cardiac output (in patients with largely normal LV
function), raises the possibility of this parameter being
used for decisions regarding the optimal timing of PVR.
In our study, we have shown that effective RVSVi
significantly correlates with exercise capacity and maybe
a potentially useful additional parameter in the decision
for PVR. Nevertheless, the decision for timing of PVR is
a complex one and should not be based primarily on a
single parameter. Rather, each case should be considered
individually: balancing the need to intervene before the
point of irreversible remodeling against the likelihood
for repeat procedures in future. The use of ventricular
volumes alone may not take into account the degree of
compensation of ventricular function. Many factors may
also influence the poorer exercise performance in oper-
ated TOF patients: not only residual PR, but also residual
right ventricular outflow tract obstruction, impaired
biventricular function and presence of ventricular or
atrial arrhythmias [25].
Abnormal cardiac function and and haemodynamic
abnormalities secondary to residual PR and other residual
defects may only appear after longer periods of follow-up.
As time passes, PR leads eventually to worsening right
ventricle enlargement and dysfunction, with consequent
biventricular dyssynchrony, progression to heart failure,
and poor performance at physical exercise. The chal-
lenge is to identify the optimal timing prior to irreversible
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is another important consideration in the decision for
PVR. Ventricular and atrial arrhythmias occur not uncom-
monly after correction of TOF and are one of the causes
for sudden cardiac death in this group of patients [1,26].
Both the ESC and CCS guidelines recommend PVR in the
presence of sustained atrial or ventricular arrhythmias
[10,11]. In our cohort of repaired TOF patients, none had
any malignant arrhythmias necessitating PVR.
The strength of our study lies in the unique set of data
on exercise capacity in operated TOF patients with sig-
nificant PR, which provides insights into the relationship
between exercise capacity and CMR findings in this
group of patients. The main limitations of our study is
its retrospective and cross-sectional design, with lack of
longitudinal CPET and CMR data. The longitudinal re-
lationship between exercise capacity and biventricular
volumes and function were not addressed and are best
studied in a prospective cohort. The retrospective na-
ture of our study also did not allow us to collect data on
exercise habits and behavior which may be significant in
this group of young patients and could better help ex-
plain our findings. Further, most subjects had near nor-
mal exercise capacity, which limits extrapolation of the
findings to TOF cases with end-stage symptoms. Finally,
our study had been performed in a single centre with
relatively few patient number. This could have inadvert-
ently introduced some bias and affect the generalizability
of our results.Conclusion
Although the majority of our TOF subjects had near
normal exercise capacity; objective measures of Mets
achieved, VO2max and peak oygen pulse were significant
lower than controls. Increased PR fraction in TOF pa-
tients was associated with lower AT. Indexed effective
RV stroke volume, which we postulate to be a measure
of LV preload in the presence of significant PR, was
positively associated with VO2max and Mets achieved.
This may potentially be used as a predictor of exercise
capacity in repaired TOF with significant PR.Abbreviations
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